Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease
Status:
Withdrawn
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
To date, few studies have assessed the efficacy and safety of Cannabinoids, compounds derived
from the Cannabis plant, in patients with Crohn's disease. Our study seeks to pilot a
randomized, placebo-controlled trial assessing the efficacy and safety of oral cannabinoids
as an adjunct therapy in patients with Crohn's disease.